Metropolitan Life Insurance Company (MetLife)’s Alaunos Therapeutics TCRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-172
Closed -$28.1K 2651
2021
Q4
$28.1K Sell
172
-27
-14% -$4.42K ﹤0.01% 2740
2021
Q3
$54.4K Sell
199
-195
-49% -$53.3K ﹤0.01% 2748
2021
Q2
$156K Sell
394
-5
-1% -$1.98K ﹤0.01% 2326
2021
Q1
$215K Sell
399
-1
-0.3% -$540 ﹤0.01% 1970
2020
Q4
$151K Sell
400
-10
-2% -$3.78K ﹤0.01% 2128
2020
Q3
$155K Sell
410
-40
-9% -$15.1K ﹤0.01% 1939
2020
Q2
$221K Buy
450
+171
+61% +$84.2K ﹤0.01% 1729
2020
Q1
$103K Sell
279
-2
-0.7% -$735 ﹤0.01% 2014
2019
Q4
$199K Sell
281
-81
-22% -$57.4K ﹤0.01% 1934
2019
Q3
$232K Buy
362
+52
+17% +$33.4K ﹤0.01% 1776
2019
Q2
$271K Buy
310
+11
+4% +$9.62K ﹤0.01% 1683
2019
Q1
$173K Buy
299
+3
+1% +$1.73K ﹤0.01% 2000
2018
Q4
$83.1K Hold
296
﹤0.01% 2386
2018
Q3
$142K Hold
296
﹤0.01% 2238
2018
Q2
$134K Buy
296
+24
+9% +$10.9K ﹤0.01% 2172
2018
Q1
$160K Buy
272
+48
+21% +$28.2K ﹤0.01% 2034
2017
Q4
$139K Buy
+224
New +$139K ﹤0.01% 2121
2017
Q3
Sell
-591
Closed -$552K 2524
2017
Q2
$552K Hold
591
﹤0.01% 1619
2017
Q1
$562K Buy
591
+25
+4% +$23.8K ﹤0.01% 1574
2016
Q4
$454K Sell
566
-32
-5% -$25.7K ﹤0.01% 1800
2016
Q3
$505K Buy
598
+1
+0.2% +$844 ﹤0.01% 1700
2016
Q2
$492K Buy
597
+60
+11% +$49.4K ﹤0.01% 1714
2016
Q1
$597K Hold
537
﹤0.01% 1480
2015
Q4
$669K Hold
537
0.01% 1438
2015
Q3
$726K Hold
537
0.01% 1380
2015
Q2
$966K Buy
537
+65
+14% +$117K 0.01% 1311
2015
Q1
$762K Buy
472
+70
+17% +$113K 0.01% 1359
2014
Q4
$306K Hold
402
﹤0.01% 2116
2014
Q3
$159K Hold
402
﹤0.01% 2524
2014
Q2
$243K Hold
402
﹤0.01% 2365
2014
Q1
$276K Hold
402
﹤0.01% 2252
2013
Q4
$262K Hold
402
﹤0.01% 2280
2013
Q3
$238K Buy
+402
New +$238K ﹤0.01% 2286